Strategic report Governance IFRS financial statements Other information Notes to the consolidated financial statements Continued 23 Loans This note analyses the loans our Group companies have made, the majority of which are mortgage loans.
a Carrying amounts The carrying amounts of loans at 31 December 2017 and 2016 were as follows: 2017 2016 At fair value At fair value through profit through profit or loss other At amortised or loss other At amortised than trading cost Total than trading cost Total m m m m m m Policy loans 1 792 793 1 881 882 Loans to banks 554 1,970 2,524 569 2,010 2,579 Healthcare, infrastructure & PFI other loans 3,563 3,563 2,460 2,460 1 UK securitised mortgage loans see note 24 2,463 2,463 2,424 2,424 1 Non-securitised mortgage loans 17,817 17,817 15,829 1 15,830 Loans to brokers and other intermediaries 180 180 170 170 Other loans 523 523 514 514 Total 24,398 3,465 27,863 21,283 3,576 24,859 Less: Amounts classified as held for sale 6 6 75 75 24,392 3,465 27,857 21,283 3,501 24,784 1 Following a review of the classification of mortgage loans, 4,992 million has been transferred from securitised to non-securitised mortgage loans in 2016.
The net impact on total loans is nil.
Of the above total loans, 26,206 million 2016: 23,432 million are due to be recovered in more than one year after the statement of financial position date.
Loans at fair value Fair values have been calculated by using cash flow models appropriate for each portfolio of mortgages.
Further details of the fair value methodology and models utilised are given in note 22 g. The cumulative change in fair value of loans attributable to changes in credit risk to 31 December 2017 was a 1,090 million loss 2016: 1,735 million loss.
Non-securitised mortgage loans include 3.4 billion 2016: 3.3 billion relating to UK primary healthcare and PFI businesses which are secured against General Practitioner premises, other primary health-related premises or other emergency services related premises.
For all such loans, government support is provided through either direct funding or reimbursement of rental payments to the tenants to meet income service and provide for the debt to be reduced substantially over the term of the loan.
Although the loan principal is not , the nature of these businesses and premises provides considerable comfort of an ongoing business model and low risk of default.
Healthcare, Infrastructure and PFI other loans of 3.6 billion 2016: 2.5 billion are secured against the income from healthcare and educational premises.
Loans at amortised cost The fair value of these loans at 31 December 2017 was 3,404 million 2016: 3,497 million.
b Analysis of loans carried at amortised cost 2017 2016 Amortised Carrying Amortised Carrying Cost Impairment Value Cost Impairment Value m m m m m m Policy loans 792 792 881 881 Loans to banks 1,970 1,970 2,010 2,010 Non-securitised mortgage loans 9 9 8 7 1 Loans to brokers and other intermediaries 180 180 170 170 Other loans 523 523 514 514 Total 3,474 9 3,465 3,583 7 3,576 The movements in the impairment provisions on these loans for the years ended 31 December 2017 and 2016 were as follows: 2017 2016 m m At 1 January 7 6 Increase during the year 2 1 At 31 December 9 7 Aviva plc Annual report and accounts 2017 149
